Correlation Between Immunome and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Immunome and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunome and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunome and X4 Pharmaceuticals, you can compare the effects of market volatilities on Immunome and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunome with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunome and X4 Pharmaceuticals.
Diversification Opportunities for Immunome and X4 Pharmaceuticals
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Immunome and XFOR is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Immunome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunome are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Immunome i.e., Immunome and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Immunome and X4 Pharmaceuticals
Given the investment horizon of 90 days Immunome is expected to generate 0.4 times more return on investment than X4 Pharmaceuticals. However, Immunome is 2.53 times less risky than X4 Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 1,159 in Immunome on September 2, 2024 and sell it today you would earn a total of 196.00 from holding Immunome or generate 16.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immunome vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Immunome |
| X4 Pharmaceuticals |
Immunome and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immunome and X4 Pharmaceuticals
The main advantage of trading using opposite Immunome and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunome position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stocks Directory Find actively traded stocks across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |